{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:29:01Z","timestamp":1777328941408,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T00:00:00Z","timestamp":1555545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dutch Poisons Information Center"},{"name":"Faculty of Veterinary Medicine"},{"name":"Radboud Institute for Molecular Sciences"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.tox.2019.04.012","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T10:52:42Z","timestamp":1555671162000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT)"],"prefix":"10.1016","volume":"422","author":[{"given":"Anne","family":"Zwartsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlijn H.C.","family":"Litjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hondebrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen J.M.W.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick","family":"Greupink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans G.M.","family":"Russel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan W.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Legler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan B.","family":"Koenderink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remco H.S.","family":"Westerink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7-8","key":"10.1016\/j.tox.2019.04.012_bib0005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuropharm.2009.07.025","article-title":"Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice","volume":"57","author":"Balcioglu","year":"2009","journal-title":"Neuropharmacology"},{"issue":"121","key":"10.1016\/j.tox.2019.04.012_bib0010","article-title":"Dopamine genetics and function in food and substance abuse","volume":"4","author":"Blum","year":"2013","journal-title":"J. Genet. Syndr. Gene Ther."},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0015","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0022-3565(25)33118-6","article-title":"Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice","volume":"221","author":"Butz","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.tox.2019.04.012_bib0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0009-9120(80)80007-5","article-title":"Gas chromatographic\/mass spectrometric analysis of methylphenidate (Ritalin) in serum","volume":"13","author":"Chan","year":"1980","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.tox.2019.04.012_bib0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF02412111","article-title":"The effect of experimentally-induced renal failure on accumulation of bupropion and its major basic metabolites in plasma and brain of guinea pigs","volume":"89","author":"DeVane","year":"1986","journal-title":"Psychopharmacology (Berl.)"},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.tox.2019.04.012_bib0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.106.110379","article-title":"Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2\/ABCC2- and MRP4\/ABCC4-mediated methotrexate transport","volume":"320","author":"El-Sheikh","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2019.04.012_bib0040","series-title":"European Drug Report 2018 - Trends and Developments","author":"EMCDDA","year":"2018"},{"issue":"7","key":"10.1016\/j.tox.2019.04.012_bib0045","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jat\/24.7.648","article-title":"An unusual multiple drug intoxication case involving citalopram","volume":"24","author":"Fu","year":"2000","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.tox.2019.04.012_bib0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004583-198201000-00005","article-title":"Clinical studies of methylphenidate serum levels in children and adults","volume":"21","author":"Gualtieri","year":"1982","journal-title":"J. Am. Acad. Child Psychiatry"},{"issue":"4","key":"10.1016\/j.tox.2019.04.012_bib0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sj.tpj.6500106","article-title":"Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders","volume":"2","author":"Hahn","year":"2002","journal-title":"Pharmacogenomics J."},{"issue":"12","key":"10.1016\/j.tox.2019.04.012_bib0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/mp.2013.102","article-title":"De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder","volume":"18","author":"Hamilton","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"19","key":"10.1016\/j.tox.2019.04.012_bib0065","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1074\/jbc.RA118.001753","article-title":"Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes","volume":"293","author":"Herborg","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.tox.2019.04.012_bib0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/FTD.0000000000000183","article-title":"Effect of CYP2B6*6 on steady-state serum concentrations of bupropion and hydroxybupropion in psychiatric patients: a study based on therapeutic drug monitoring data","volume":"37","author":"Hoiseth","year":"2015","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.tox.2019.04.012_bib0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2017.10.022","article-title":"Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data?","volume":"182","author":"Hondebrink","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.tox.2019.04.012_bib0080","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.clinthera.2005.11.011","article-title":"Bupropion for major depressive disorder: pharmacokinetic and formulation considerations","volume":"27","author":"Jefferson","year":"2005","journal-title":"Clin. Ther."},{"issue":"2","key":"10.1016\/j.tox.2019.04.012_bib0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-200262002-00002","article-title":"Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation","volume":"62","author":"Johnston","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.tox.2019.04.012_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.forsciint.2016.08.015","article-title":"Post-mortem concentrations of drugs determined in femoral blood in single-drug fatalities compared with multi-drug poisoning deaths","volume":"267","author":"Jones","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"17","key":"10.1016\/j.tox.2019.04.012_bib0095","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the united states from 1999-2012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.tox.2019.04.012_bib0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1586\/ern.10.186","article-title":"Pharmacogenetics of antidepressant response","volume":"11","author":"Keers","year":"2011","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.tox.2019.04.012_bib0105","series-title":"Cocaine Overdose, Primer on the Autonomic Nervous System","first-page":"577","author":"Kontak","year":"2012"},{"key":"10.1016\/j.tox.2019.04.012_bib0110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejphar.2014.11.045","article-title":"The many different faces of major depression: it is time for personalized medicine","volume":"753","author":"Korte","year":"2015","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.tox.2019.04.012_bib0115","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.paf.0000188276.33030.dd","article-title":"Case report of a fatal intoxication by citalopram","volume":"26","author":"Luchini","year":"2005","journal-title":"Am. J. Forensic Med. Pathol."},{"issue":"11","key":"10.1016\/j.tox.2019.04.012_bib0120","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.biopsych.2004.10.011","article-title":"The dopamine transporter and attention-deficit\/hyperactivity disorder","volume":"57","author":"Madras","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12012-012-9159-x","article-title":"Acute massive pulmonary thromboembolism due to acute intoxication by duloxetine: a case report","volume":"12","author":"Mari","year":"2012","journal-title":"Cardiovasc. Toxicol."},{"issue":"4","key":"10.1016\/j.tox.2019.04.012_bib0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/00912700022009080","article-title":"Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation","volume":"40","author":"Modi","year":"2000","journal-title":"J. Clin. Pharmacol."},{"issue":"24","key":"10.1016\/j.tox.2019.04.012_bib0135","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1523\/JNEUROSCI.23-24-08480.2003","article-title":"Mitogen-activated protein kinase regulates dopamine transporter surface expression and dopamine transport capacity","volume":"23","author":"Moron","year":"2003","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.tox.2019.04.012_bib0140","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/pgs.12.1","article-title":"Pharmacogenetics of antidepressant drugs: current clinical practice and future directions","volume":"13","author":"Narasimhan","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"7397","key":"10.1016\/j.tox.2019.04.012_bib0145","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature11011","article-title":"Patterns and rates of exonic de novo mutations in autism spectrum disorders","volume":"485","author":"Neale","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/jat\/bkx098","article-title":"Reference Brain\/Blood concentrations of citalopram, duloxetine, Mirtazapine and sertraline","volume":"42","author":"Nedahl","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"6","key":"10.1016\/j.tox.2019.04.012_bib0155","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/ana.20089","article-title":"The dopamine transporter: importance in Parkinson\u2019s disease","volume":"55","author":"Nutt","year":"2004","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/JCP.0b013e318218f503","article-title":"Association between citalopram serum levels and clinical improvement of patients with major depression","volume":"31","author":"Ostad Haji","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.tox.2019.04.012_bib0165","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/0091270009359524","article-title":"Dose-related reduction in bupropion plasma concentrations by ritonavir","volume":"50","author":"Park","year":"2010","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/YIC.0000000000000114","article-title":"Measuring citalopram in blood and cerebrospinal fluid: revealing a distribution pattern that differs from other antidepressants","volume":"31","author":"Paulzen","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.tox.2019.04.012_bib0175","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/BF00543497","article-title":"Alcohol and bupropion pharmacokinetics in healthy male volunteers","volume":"26","author":"Posner","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.tox.2019.04.012_bib0180","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/10408444.2012.725029","article-title":"Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions","volume":"42","author":"Rietjens","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"issue":"6","key":"10.1016\/j.tox.2019.04.012_bib0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.alcohol.2008.04.009","article-title":"Ethanol potentiates dopamine uptake and increases cell surface distribution of dopamine transporters expressed in SK-N-SH and HEK-293 cells","volume":"42","author":"Riherd","year":"2008","journal-title":"Alcohol"},{"issue":"2","key":"10.1016\/j.tox.2019.04.012_bib0190","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jat\/bku139","article-title":"Brain tissue: a viable postmortem toxicological specimen","volume":"39","author":"Rohrig","year":"2015","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(01)02058-4","article-title":"Substantial loss of substrate by diffusion during uptake in HEK-293 cells expressing neurotransmitter transporters","volume":"309","author":"Scholze","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.tox.2019.04.012_bib0200","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3109\/15563650.2010.516263","article-title":"Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation","volume":"48","author":"Seger","year":"2010","journal-title":"Clin. Toxicol. (Phila)"},{"issue":"1-3","key":"10.1016\/j.tox.2019.04.012_bib0205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.forsciint.2010.02.014","article-title":"First nationwide study on driving under the influence of drugs in Switzerland","volume":"198","author":"Senna","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.tox.2019.04.012_bib0210","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1756-0500-6-220","article-title":"Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence","volume":"6","author":"Simmler","year":"2013","journal-title":"BMC Res. Notes"},{"issue":"5","key":"10.1016\/j.tox.2019.04.012_bib0215","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0197-0186(99)00083-2","article-title":"HEK-293 cells expressing the human dopamine transporter are susceptible to low concentrations of 1-methyl-4-phenylpyridine (MPP+) via impairment of energy metabolism","volume":"35","author":"Storch","year":"1999","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.tox.2019.04.012_bib0220","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0090-9556(25)08996-2","article-title":"Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs","volume":"14","author":"Suckow","year":"1986","journal-title":"Drug Metab. Dispos."},{"issue":"12","key":"10.1016\/j.tox.2019.04.012_bib0225","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1128\/AAC.01471-16","article-title":"Moxifloxacin is a potent In vitro inhibitor of OCT- and MATE-mediated transport of metformin and ethambutol","volume":"60","author":"te Brake","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.vascn.2004.08.014","article-title":"HEK293 cell line: a vehicle for the expression of recombinant proteins","volume":"51","author":"Thomas","year":"2005","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"1","key":"10.1016\/j.tox.2019.04.012_bib0235","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrn1008","article-title":"Plasma membrane monoamine transporters: structure, regulation and function","volume":"4","author":"Torres","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tox.2019.04.012_bib0240","series-title":"World Drug Report 2018","author":"UNODC","year":"2018"},{"issue":"4","key":"10.1016\/j.tox.2019.04.012_bib0245","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuroimage.2012.03.014","article-title":"Effect of paroxetine and bupropion on human resting brain perfusion: an arterial spin labeling study","volume":"61","author":"Viviani","year":"2012","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.tox.2019.04.012_bib0250","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00213-002-1340-7","article-title":"Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma","volume":"166","author":"Volkow","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"issue":"24","key":"10.1016\/j.tox.2019.04.012_bib0255","doi-asserted-by":"crossref","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","article-title":"Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction","volume":"26","author":"Volkow","year":"2006","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.tox.2019.04.012_bib0260","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00414-008-0287-6","article-title":"Determination of antidepressants in human postmortem blood, brain tissue, and hair using gas chromatography-mass spectrometry","volume":"123","author":"Wille","year":"2009","journal-title":"Int. J. Legal Med."},{"issue":"12","key":"10.1016\/j.tox.2019.04.012_bib0265","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s12272-009-2201-2","article-title":"N-methyl amine-substituted fluoxetine derivatives: new dopamine transporter inhibitors","volume":"32","author":"Yoon","year":"2009","journal-title":"Arch. Pharm. Res."},{"issue":"5","key":"10.1016\/j.tox.2019.04.012_bib0270","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/187152708786927877","article-title":"Role of the dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse","volume":"7","author":"Zhu","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"Pt 1","key":"10.1016\/j.tox.2019.04.012_bib0275","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.tiv.2017.05.010","article-title":"Measuring inhibition of monoamine reuptake transporters by new psychoactive substances (NPS) in real-time using a high-throughput, fluorescence-based assay","volume":"45","author":"Zwartsen","year":"2017","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tox.2019.04.012_bib0280","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuro.2018.03.007","article-title":"Neurotoxicity screening of new psychoactive substances (NPS): effects on neuronal activity in rat cortical cultures using microelectrode arrays (MEA)","volume":"66","author":"Zwartsen","year":"2018","journal-title":"Neurotoxicology"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19301283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X19301283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:41:15Z","timestamp":1759534875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X19301283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":56,"alternative-id":["S0300483X19301283"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2019.04.012","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential effects of psychoactive substances on human wildtype and polymorphic T356M dopamine transporters (DAT)","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2019.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}